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Abstract: The evolutionary conserved N-alpha acetyltransferase Naa40p is among the most selective
N-terminal acetyltransferases (NATs) identified to date. Here we identified a conserved N-terminally
truncated Naa40p proteoform named Naa40p25 or short Naa40p (Naa40S). Intriguingly, although
upon ectopic expression in yeast, both Naa40p proteoforms were capable of restoring N-terminal
acetylation of the characterized yeast histone H2A Naa40p substrate, the Naa40p histone H4 sub-
strate remained N-terminally free in human haploid cells specifically deleted for canonical Naa40p27
or 237 amino acid long Naa40p (Naa40L), but expressing Naa40S. Interestingly, human Naa40L
and Naa40S displayed differential expression and subcellular localization patterns by exhibiting a
principal nuclear and cytoplasmic localization, respectively. Furthermore, Naa40L was shown to be
N-terminally myristoylated and to interact with N-myristoyltransferase 1 (NMT1), implicating NMT1
in steering Naa40L nuclear import. Differential interactomics data obtained by biotin-dependent
proximity labeling (BioID) further hints to context-dependent roles of Naa40p proteoforms. More
specifically, with Naa40S representing the main co-translationally acting actor, the interactome of
Naa40L was enriched for nucleolar proteins implicated in ribosome biogenesis and the assembly
of ribonucleoprotein particles, overall indicating a proteoform-specific segregation of previously
reported Naa40p activities. Finally, the yeast histone variant H2A.Z and the transcriptionally regu-
latory protein Lge1 were identified as novel Naa40p substrates, expanding the restricted substrate
repertoire of Naa40p with two additional members and further confirming Lge1 as being the first
redundant yNatA and yNatD substrate identified to date.
Keywords: N-terminal proteoforms; N-alpha acetyltransferase; N-terminal acetylation; NAA40;
Naa40S; biotin-dependent proximity labeling (BioID); alternative translation initiation; N-terminal
myristoylation; NMT1
1. Introduction
Largely believed to occur co-translationally when a protein N-terminus emerges from
the ribosomal peptide exit channel, N-terminal acetylation (Nt-acetylation) represents a
widespread modification affecting most intracellular proteins in higher eukaryotes [1]. Be-
cause of its diverse functional outcomes, however, its consequences remain largely underex-
plored. Although the responsible enzymes—N-terminal acetyltransferases or NATs—and
their substrate specificities are generally conserved in eukaryotes (reviewed in [2]), a higher
eukaryotic-specific NAT, namely NatF [3] was recently found to partially account for the
observed variations in Nt-acetylation patterns among different eukaryotes [1,4,5]. Further-
more, while representing an infrequent modification in prokaryotes [6–8], post-translational
Nt-acetylation has also been observed in archaea and in plant [9], and more recently, a ded-
icated NAT responsible for post-translational Nt-acetylation of actin was discovered [10].
To bring the catalytic NAT subunit—responsible for the transfer of the acetyl moiety
from acetyl-coenzyme A to the α-amino group of the N-terminal amino acid—in close
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proximity to the nascent polypeptide, NATs frequently comprise one or more auxiliary
subunit(s) implicated in ribosome binding [2]. However, N-alpha acetyltransferase 40
(Naa40p) also known as NatD, Nat11, Patt1 or Nat4, was shown to be active as a monomeric
enzyme. Furthermore, as compared to most other NATs displaying relative extensive
substrate repertoires and with NatA putatively targeting up to ~50% of the proteome [3],
Naa40p displays a restricted substrate specificity over a few specific histone N-termini
and therefore represents one of the most substrate-selective NATs identified to date [11].
More specifically, Naa40p activity over histones H2A and H4 was originally discovered by
identification of the Nt-acetylated Ser-starting N-termini of H2A and H4 in yeast deleted
for NatA (yNatA∆), a type of N-termini typically targeted by NatA [3]. Both yeast (NAT4,
subsequently referred to by the alias yNAA40 [12]) [13] and human NAA40 (hNAA40) [14]
were previously cloned and characterized, and we reported that these orthologs genes
encode proteins displaying overlapping substrate specificities [14]. Interestingly, while
ribosome-association was found for both yeast and human orthologs, hNaa40p and mouse
Naa40 (mNaa40p) was reported to additionally locate in the nucleus [14,15], indicating
that Naa40p might carry out co- as well as post-translational activities [14,16].
Due to the additional presence of a unique and complementary substrate binding
pocket extending the specificity beyond the second amino acid residue of cognate sub-
strates, Naa40p is exceptional in that it has sequence requirements for the first four residues
of its substrates [11,14]. More specifically, X-ray structure determination of Naa40p re-
vealed structural features tailored for specifically accommodating the N-termini of H4 and
H2A [11] (i.e., Ser-Gly-Arg-Gly- starting N-termini in case of human H4 and H2A).
Interestingly, while displaying an overall mixed α/β GCN5-like fold similar to other
NAT structures, Naa40p possesses a unique N-terminal segment adopting an extra helix-
loop-strand secondary structural element (residues 24–51 in hNaa40p) which is implicated
in cognate substrate binding and stability maintenance of the catalytic core of Naa40p,
thereby serving a potential analog role as compared to the auxiliary subunits of other major
NAT complexes [11].
Notably, S. cerevisiae H2A has a divergent Ser-Gly-Gly-Lys- N-terminal sequence and
hNaa40p was unable to restore Nt-acetylation of yeast H2A (yH2A) in contrast to being
able to restore yH4 Nt-acetylation, indicating that yNaa40p likely evolved to specifically
accommodate both divergent yeast histone N-termini.
Besides histone H4 and H2A being confirmed Naa40p substrates, we previously
reported four other putative yNaa40p substrates. More specifically in case of Scl1, Ypi1,
Dph1 and Lge1, their corresponding Ser-Gly- starting N-termini remained (partially) Nt-
acetylated in yeast deleted for yNatA [17], an observation in line with H2A and H4 being
Nt-acetylated in the same yeast background.
Although deletion of NAA40 in yeast (ynaa40∆) was associated with reduced growth
in the presence of various chemicals such as transcription inhibitors—a phenotype which
was enhanced upon additional mutation of H4 lysine residues targeted for protein mod-
ifications making up the histone code [16]—it was only in 2013 that a first molecular
and biological function of H4 Nt-acetylation was elucidated. More specifically, by the
observed inverse correlation and interplay between H4 Nt-acetylation and asymmetric
Arg3 methylation in regulating ribosomal RNA (rRNA) gene expression, Schiza et al. pro-
claimed H4 Nt- acetylation to serve as a sensor for cell growth [18]. Consistently, hNAA40
knockdown in colon cancer cells was shown to reduce rRNA expression [19], hinting to a
similar role for both orthologs in regulating rDNA expression and consequently ribosome
biogenesis. Furthermore, by its observed aberrant expression in hepatocellular carcinoma
and high variable expression in different cancer types (Human Protein Atlas project),
Naa40p has been implicated in disease [15] and was additionally shown to play a role in
hepatic lipid metabolism [20].
In the present study, we identified a conserved 21 amino acid Nt-truncated Naa40p
proteoform named Naa40p25 or short Naa40 (Naa40S). As compared to canonical Naa40p27
or long Naa40 (Naa40L), enzymatically active Naa40S displayed a differential expression
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and subcellular localization pattern. Furthermore, by the observed association of hNaa40S
with the translational machinery and hNaa40L being implicated in nucleolar ribosome bio-
genesis and ribonucleoprotein assembly, interactomics data untangled previously reported
Naa40p activities. Overall, our data point to a possible proteoform-specific segregation of
post- and cotranslational Naa40p proteoform activities.
2. Results
2.1. Identification of an Alternative N-Terminally Truncated Proteoform of Human N-Terminal
Acetyltransferase Naa40
We previously reported that human hNAA40 encodes a 237-amino acid (AA) long
protein with strong similarity to yNaa40p [14]. As inferred from their overlapping substrate
specificities, yNAA40 and hNAA40 were catalogued as orthologs genes [14]. In another
study, studying the translation initiation landscape of mice and men and the expression of
multiple molecular forms of proteins from a single gene (i.e., proteoforms), we reported
the identification of an alternative, shorter hNaa40p proteoform by the identification of
its corresponding Nt-acetylated N-terminus MDAVCAKVDAANR (Figure 1A), hereafter
referred to as short Naa40 (Naa40S). Naa40S is generated upon translation initiation at the
second in-frame ATG codon downstream of the canonical, database-annotated translation
initiation start site (dbTIS) ([21] and Figure 1A).
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VDAANR (orange) matching amino acid sequence positions 22 to 34 of full-length canonical 
hNaa40L (Q86UY6, length: 237 AA). The MS2 spectrum matches a doubly charged precursor mass 
of m/z 762.3546, corresponding to the modified peptide sequence Ac-M < Mox > DAVC < Cmm > 
AK < AcD3 > VDAANR, and with ’Ac-‘, ’Cmm’ and ‘AcD3′ denoting an acetyl, carbamidomethyl 
and (trideutero)acetyl moiety [21]. Tryptic peptide identifications reported in ProteomicsDB ([22], 
accessed January 2021) are indicated in bold in the hNaa40L protein sequence overall providing a 
sequence coverage of 80.17% and with the reported AAMDAVCAK peptide indicative of hNaa40L 
expression (Figure S1) (B) Expression profiling of endogenous hNaa40p in different human cell lines 
by Western blot analysis indicates expression of hNaa40L in all 3 cell lines and prominent expression 
of the short proteoform of hNaa40p (hNaa40S) in the pro-myelocytic leukemia cell lines HL-60. A 
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Figure 1. Identification and expression analys s of a novel N-t rmi ally truncated hNaa40p proteoform, hNaa40S. (A) Mass
spectrometric (MS) identification of an Nt-truncated Naa40p proteoform (hNaa40S) raised upon translation initiation at a
downstream translation initiation start site (dTIS) as demonstrated by the MS2-based identification of the Nt-acetylated
peptide MDAVCAKVDAANR (orange) matching amino acid sequence positions 22 to 34 of full-length canonical hNaa40L
(Q86UY6, length: 237 AA). The MS2 spectrum matches a doubly charged prec rsor mass of m/z 762.3546, corresp nding
to the modified peptide sequence Ac-M < Mox > DAVC < Cmm > AK < AcD3 > VDAANR, and with ‘Ac-’, ‘ mm’ and
‘AcD3’ denoting an acetyl, carbamidomethyl and (trideutero)acetyl moiety [21]. Tryptic peptide identifications reported
in ProteomicsDB ([22], accessed January 2021) are indicated in bold in the hNaa40L protein sequence overall providing a
sequence coverage of 80.17% and with the reported AAMDAVCAK peptide indicative of hNaa40L expression (Figure S1)
(B) Expression profiling of endogenous hNaa40p in different human cell lines by Western blot analysis indicates expression
of hNaa40L in all 3 cell lines and prominent expres ion of th short prote form of hNa 40p (hNaa40S) in the pro-myelocytic
leukemia cell lines HL-60. A non-specific band (*) serves as loading control.
When looking at endogenous Naa40p expression by means of Western analysis, and
while the canonical Naa40p proteoform of Naa40—Naa40p27 or long Naa40L—appears
the most common proteoform of expressed hNAA40 in human cells, expression of hNaa40S
could be demonstrated in certain cell lines such as the human (pro-)myelocytic leukemia
cell lines HL-60 (Figure 1B) and K-562 (Figure 2B). Furthermore, the corresponding Nt-
peptide of hNaa40S was previously also identified by N-terminal proteomics analysis
performed in Jurkat, HCT 116 and B-cells [21].
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Interestingly, when differentiating K-562 cells with the phorbol ester and diacylglyc-
erol analog phorbol 12-myristate 13-acetate (PMA) into megakaryocytes via the mitogen-
activated protein kinase pathway [23] (Figure 2A), hNaa40L expression remained sta-
ble over the differentiation process, whereas hNaa40S was significantly down-regulated
(Figure 2B,C), indicating that Naa40p proteoform expression can be differentially regulated.
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Figure 2. Differentiation of K-562 cells into megakaryocytes induces specific down-regulation of hNaa40S. (A) Morphology
of phorbol 12-myristate 13-acetate (PMA) differentiated K-562 cells. Control K-562 cells (a), K-562 cells treated with PMA
(40 nM) for 5 h, 1 day (d.), 2 d., 3 d. and 4 d. respectively (b–f) sh ws h llmarks of m gak ryocytic differentiation upon PMA
treatment. Images are annotated with a 50 µm scale bar. (B,C) Expression profiling of endogenous hNaa40p proteoforms at
various time points of PMA treatment indicates specific down-regulation of hNaa40S in PMA-differentiated K-562 cells by
Western blot analysis (with GAPDH ((Glyceraldehyde-3-phosphate dehydrogenase), 36 kDa) serving as loading control) (B),
and following the identification by N-terminal proteomics (C). Here, composite MS spectra of the Nt-peptide originating
from hNaa40S (MDAVCAKVDAANR) (see also Figure 1) in the control (light L-Arg SILAC (stable isotope-labeling by
amino acids in cell culture) label) and 4 and 6 days PMA treated setups (heavy 13C615N4 L-Arg SILAC label) are shown. In
both setups, in vitro 3C2D3-acetylation w s performed at the protein level in combination with differentia L-Arg SILAC
labeling [24] which allows for the calculation of the extent of Nt-acetylation as well as the relative quantification of Nt-
peptide abundancy [25,26]. Overall, the N-terminus of hNaa40S was fully Nt-acetylated in all setups analyzed and the
relative concentration of hNaa40S lowered after 4 d. (p ≤ 0.2) and 6 d. following PMA treatment (p ≤ 0.01).
Although the differentially spliced ENST00000542163.1 transcript can give rise to
expression of the shorter 216 AA long hNaa40p proteoform hNaa40S (Figure 3A), in vitro
(and cellular, see below) transcription/translation assays making use of full-length hNAA40
cDNA, indicated that hNaa40S translation can also potentially arise from alternative trans-
lation initiation. When considering the Kozak motif (i.e., the consensus Kozak motif
being gcc[A/G]ccAUGG), the likelihood of the second in-frame AUG codon to serve as
downstream TIS (dTIS) was predicted 0.33 versus 0.92 for the first AUG codon (dbTIS)
by translation initiation prediction at http://atgpr.dbcls.jp, accessed on 1 December 2020,
overall indicating that the second in-frame AUG codon may potentially serve as an alter-
native TIS. Alternative TIS codon and sequence context alignment in the corresponding
NAA40 loci of representative mammalian genomic sequences (alignment set hg38_58 in-
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cluding human, chimp, mouse, rabbit, dog and cow genomic sequences) indicated that the
alternative TIS and its surrounding Kozak consensus motif is highly conserved (Figure 3B).
Further of note, this alternative TIS also appears conserved in NAA40 sequences of more
distantly related organisms such as Xenopus tropicalis (B1H2T3), Gallus (A0A1D5P6P4) and
Danio rerio (Q568K5).
Figure 3. Alternative splicing or alternative translation can give rise to hNaa40S expression. (A) Scheme depicting two
alternatively spliced hNAA40 transcripts; being transcript ENST00000377793.9 (3649 bp, transcript expected to code for the
main functional isoform with transcript support level 1 according to the APPRIS database (http://appris.bioinfo.cnio.es,
accessed on 1 December 2020)) and transcript ENST00000542163.1 (1035 bp, transcript support level 2). Exons are indicated
as boxes and corresponding non-coding and coding regions colored grey and orange, respectively. When considering the
longest transcript, hNaa40L and hNaa40S translation initiates at the first (black arrow) and second in-frame AUG codon
(orange arrow), respectively. Exon 1 encodes for the first 2 amino acids of hNaa40L. The protein sequence of hNaa40L
(aa 1-237) with an indication of corresponding secondary structure elements of structure PDB:4U9V is provided above the
transcripts. (B) Codon alignment of representative mammalian genomic sequences (alignment set hg38_58) in the vicinity
of the canonical, database-annotated AUG TIS (dbTIS) (matching the human chr11:63939079-63939102 sequence indicated
below) and the downstream AUG TIS (dTIS) (chr11:63945879-63945917 in human) of the NAA40 locus using WebLogo. The
heights of the nucleotides are indicative for their degree of conservation at the indicated position [27]. (C) Autoradiograph
showing translation initiation of in vitro transcribed hNAA40 at the AUG start codons encoding M1 (black arrowhead)
and M22 (dashed arrowhead). For this, wild type (1) and a dTIS mutagenized (mutation of ATG encoding M22 to CTG
(dTIS > CTG)) hNAA40 pOTB7 constructs were in vitro transcribed and translated, and radiolabeled proteins visualized by
radiography following sodium dodecyl sulfate (SDS)-PAGE and electroblotting.
2.2. hNaa40S N-Terminally Acetylates Yeast Histone H4
Since Naa40S retains the GNAT (GCN5-related N-acetyltransferase superfamily) fold
(aa 63-216 in hNaa40L), a domain implicated in Ac-CoA binding and substrate recog-
nition [28], we assessed whether hNaa40S was enzymatically active and displayed the
same substrate specificity and physiological substrate repertoire as hNaa40L. For this, we
ectopically expressed hNaa40L and hNaa40S in yeast as we previously demonstrated that
hNaa40 expression rescued H4 Nt-acetylation in yeast lacking NAA40 (ynaa40∆). Specific
expression of the hNaa40S and hNaa40L proteoforms in yeast was confirmed by Western
blot analysis (Figure 4). Histone extractions followed by in-gel-stable isotope labeling
(ISIL), protein digestion and LC-MS/MS was performed to assess the N-acetylation sta-
tus of histone N-termini as described previously [14]. When comparatively analyzing
the N-acetylation states of identified histone N-termini originating from control yNAA40,
ynaa40∆ and hNAA40 or hNAA40S yeast, we found that the previously characterized
yNaa40p and hNaa40L substrate histone H4 was also Nt-acetylated when expressing
hNaa40S, while as expected, the N-free form of the Ser-Gly-Gly-Lys- starting N-terminus
of yH2A—previously identified as being an exclusive yNaa40p substrate—could only be
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observed in the hNaa40S expressing strain ([14] and data not shown). Furthermore, as
inferred from the N-acetylation states in the different yeast setups analyzed, the conserved
and replication independent yeast H2A variant H2A.Z, encoded by HTZ1 (YOLO12C)
and differing in its N-terminal sequence from the other two yeast H2A isoforms (H2A.1
and H2A.2), was here identified as a novel Naa40p yeast substrate. More specifically, the
Ser-Gly-Lys-Ala- starting N-terminus of H2A.Z was identified as being Nt-acetylated in the
control (yNAA40) and both hNAA40 setups, while the N-free form was only observed in
the ynaa40∆ setup (Figure 4). Overall, the discovery of H2A.Z as a novel Naa40p substrate
adds yet another histone member to the limited set of physiological Naa40p substrates
identified to date.
Figure 4. Ectopic expression of hNaa40L and hNaa40S in ynaa40∆ yeast rescues N-acetylation of the newly identified in vivo
yNaa40p substrate H2A.Z. Besides the identification of various N-acetylated forms of the mature N-terminus of yH2A.Z
(2SGKAHGGKGKSGAKDSGSLR21), the fully N-free form (red MS trace, ‘0 Ac’ peak indicative of ‘no in vivo N-acetylation)
was only demonstrated in the ynaa40∆ setup as inferred from the triply charged variant observed at the higher m/z 707.398.
The 5 Da spacing between the distinct isotopic envelopes, corresponds with the gain/loss of an in vivo N-acetyl group (i.e.,
free amines were in vitro N-acetylated using 13C2D3-NHS acetate; introducing a 5 Da heavier acetyl moiety to each free
amine) [29,30]. Colored squares indicate the number of in vivo (black) and in vitro (orange) acetyl moieties present per
detected isotopic envelope. Although ynaa40 deletion reduces the overall degree of H2A.Z N-acetylation (bottom left panel),
ectopic expression of hNaa40L as well as hNaa40S restores the degree of N-acetylation of the H2A.Z N-terminus to wild
type levels. The inset in the upper right panel confirmed the specific expression of hNaa40p proteoforms hNaa40L and
hNaa40S in the y[hNAA40] and y[hNAA40S] strain, respectively. Histone H3 was probed as a loading control.
2.3. The Transcriptionally Regulatory Protein Lge1 Represents a Redundant
yNatA/yNatD Substrate
In pursuit of identifying novel Naa40p substrates besides histones H2A, H4 and
H2A.Z, we comparatively analyzed the Nt-acetylomes of control (yNAA40) and ynaa40∆
yeast by means of N-terminal proteomics [25,29,30]. As inferred from the significantly
reduced degree of Nt-acetylation of the N-terminal peptide (SGYTGNNYSR) of the yeast
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transcriptional regulatory protein Lge1 in the ynaa40∆ setup (i.e., 100% Nt-acetylated in
yNAA40 yeast opposed to only partially Nt-acetylated (73%) in ynaa40∆ yeast, respectively),
Lge1 was identified as a novel yNaa40p substrate. Since in our previous study reporting
on NatA substrates [17], Lge1 also represented one of the four Ser-Gly-starting N-termini
which displayed a significantly reduced degree—but not complete lack of—Nt-acetylation
upon yNatA deletion (82% Nt-acetylated in yNatA-∆ [17]), combined this data confirms
that yNatA as well as yNaa40p display redundant activity over Lge1 thereby identifying
Lge1 as being the first redundant yNatA/yNaa40p substrate.
2.4. hNaa40S Expression in hNAA40L Knockout Human Haploid Cells Is Accompanied with
N-Terminally Free Human Histone H4 Expression
By producing a frameshift mutation in hNAA40, a selective hNAA40L knockout was
created in the human haploid cell line HAP1 using CRISPR/Cas9 editing [31]. More
specifically, exon 2 (NM_024771) was selected for guide RNA design with guide RNA
sequence GAAGAAGCAGAAGCGGTTGG and a HAP1 clone containing a 4 bp. deletion
in exon 2 was obtained as confirmed by Sanger and RNA-sequencing (data not shown).
Expression of both hNaa40p proteoforms could be detected in HAP1 control cells but with
hNaa40S displaying a much lower expression as compared to hNaa40L (Figure 5A). Since
in theory, the frameshift still permits hNaa40S proteoform expression, Western blot analysis
probing for endogenous hNaa40p indeed confirmed the exclusive expression of hNaa40S
in two independent hNAA40L knockout (hNAA40L-) HAP1 clones (Figure 5A).
Figure 5. Residual hNaa40S proteoform expression in hNAA40L- knockout HAP1 cells is deficient
in maintaining Nt-acetylation of the hNaa40p substrate histone H4. (A) Western blotting analyses
of corresponding HAP1 WT and hNAA40L- knockout HAP1 cell lysates (originating from two
independent hNAA40 knockout clones) immunoblotted with antibodies specific for hNaa40p and
GAPDH are shown. (B) Besides the identification of various N-acetylated forms of the mature N-
terminus of human histone H4 (2SGRGKGGKGLGKGGAKR18), the fully N-free form (red MS trace)
was only demonstrated in the hNAA40- setup as inferred from the doubly charged variant observed
at a higher m/z (903.559). The 5 Da spacing between the distinct isotopic envelopes, corresponds
with the gain/loss of an in vivo N-acetyl group (i.e., free amines were in vitro N-acetylated using
13C2D3-NHS acetate; introducing a 5 Da heavier acetyl moiety to each free amine [29,30]). Colored
rectangles indicate the number of in vivo (black) and in vitro (orange) acetyl groups present per
detected isotopic envelope.
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To assess if (limited) hNaa40S expression was sufficient for maintaining hNaa40p
substrate Nt-acetylation, we interrogated the N-acetylation status of the previously char-
acterized hNaa40 substrate H4. Therefore, histone isolation followed by MS analysis was
performed as described above. Intriguingly, in the hNAA40L- HAP1 cell line expressing
residual hNaa40S, the complete N-free form of the Ser-Gly-Arg-Gly- H4 N-terminus could
be observed, indicating that H4 remained (at least partially) Nt-free (Figure 5B). This ob-
servation may indicate that hNaa40p proteoforms may display non-redundant activities,
and that expression of hNaa40L is required for (efficient) Nt-acetylation of previously
characterized histone substrates.
2.5. hNaa40L and hNaa40S Proteoforms Display a Differential Subcellular Localization
As such, despite the observed enzymatic activity of hNaa40S over endogenous
yNaa40p substrates, exclusive expression of hNaa40S in HAP-1 cells was unable to res-
cue human H4 Nt-acetylation. Since it is inconclusive whether ectopic expression of
hNaa40S in yeast acts co- and/or post-translationally and since previously, a dual nuclear
and cytosolic localization pattern of hNaa40p and mNaa40p could be observed [14,15],
we examined the subcellular localization of both hNaa40p proteoforms in various cell
lines (i.e., A-431, HEK 293T cells). For this purpose, various C-terminally Flag-tagged
hNaa40p expressing constructs were generated, encoding either wild type full-length
and thus also potential short hNaa40p (hNaa40L/S), hNaa40p expressing constructs with
mutation of the dTIS (hNaa40L(dTIS>CTG)) or dbTIS (hNaa40S(dbTIS>CTG)) (i.e., mutation
of the corresponding ATG codon—encoding either M22 or M1 of hNaa40p and serving
as dTIS and dbTIS, respectively—to CTG), besides a construct exclusively encoding the
corresponding hNaa40S coding sequence (CDS). As expected, expression of these con-
structs either resulted in the expression of both hNaa40p proteoforms (hNaa40L/S), or
solely the long (hNaa40 L(dTIS>CTG)) or short (hNaa40 S(dbTIS>CTG) and hNaa40S) hNaa40p
proteoform(s). Expression of hNaa40S from the hNaa40L/S and dbTIS mutated hNaa40p
(hNaa40 S(dbTIS>CTG)) constructs again indicates that alternative translation—and thus not
only alternative splicing—can potentially give rise to hNaa40S expression.
Interestingly, upon expression of the different constructs and performing cytoplasmic
and nuclear-associated compartment fractionation using the non-ionic detergent NP-40, a
clear enrichment of the hNaa40L in the nuclear-enriched fraction (N) could be observed
while hNaa40S displayed a (predominant) cytoplasmic localization (C) (Figure 6), an obser-
vation which could be confirmed in at least 3 independent experiments and in various cell
lines (data not shown). The dual localization pattern of hNaa40p previously observed [14]
can thus (at least in part) be explained by the differential subcellular localization of the two
hNaa40p proteoforms expressed.
Figure 6. Differential subcellular localization of hNaa40p proteoforms. A-431 cells were transiently
transfected with various C-terminally Flag-tagged hNaa40p expressing constructs encoding either
both hNaa40p (hNaa40L/S), or solely the long (hNaa40 L(dTIS>CTG)) or short (hNaa40 S(dbTIS>CTG) and
hNaa40S) hNaa40p proteoform(s). Subcellular fractions enriched for nuclear (N) and cytoplasmic
(C) proteins as well as total protein lysates (TL) were immunoblotted with antibodies specific
for Flag, Tubulin-α and Histone H3, the latter two proteins serving as cytoplasmic and nuclear
markers, respectively.
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2.6. Nuclear Localized hNaa40L Harbors a Nucleolar Localization Sequence and Is
N-Terminally Myristoylated
In line with the above observation of hNaa40L being localized in the nucleus, the
23 aa long N-terminal sequence of hNaa40L (MGRKSSKAKEKKQKRLEERAAMD) was
predicted to hold a nucleolar localization sequence (NoLS) [32]. Although still ill-defined,
NoLS and nucleolar retention signal (NoRS) sequences are rich in Arg and Lys residues
and frequently overlap with nuclear localization signals (NLSs).
Furthermore, hNaa40L was predicted as being Nt-myristoylated by the neural network
predictor Myristoylator with very high confidence (score 0.99) [33] and also identified as
being myristoylated using a proteome profiling method probing for substrates responsive
to N-myristoyltransferase (NMT) inhibition [34]. More specifically, initiator Met (iMet)-
processed protein sequences starting with an N-terminal glycine residue (e.g., Naa40L)
may be co- or post-translationally modified by 14-carbon fatty acid addition through the
action of NMTs (i.e., Nt-myristoylation). Since Nt-myristoylation has been implicated
in regulation of protein localization and nuclear protein transport [35,36] among other
regulations (as recently reviewed in [37]), we assessed the Nt-myristoylation status of
transiently expressed hNaa40p.
For this, myrisate 12-azidododecanoic acid (azidomyristate)—a non-toxic alkyl azide
analog of myristate previously shown to be converted to azidomyristoyl-CoA by fatty acyl
CoA synthetase [38]—was used for the metabolic labeling of endogenous NMT protein
substrates. As inferred from Western blot analysis following labeling of the alkyne through
copper-catalyzed azide-alkyne cycloaddition (CuAAC) with alkyn-biotin conjugate, op-
timal metabolic protein incorporation was achieved after supplementing HCT 116 cell
cultures for 8 (Figure 7) or 24 h (data not shown) with 50 to 100 µM azidomyristate.
Figure 7. Azidomyristoylation of transiently expressed hNaa40L in HCT 116 cells. (Transiently hNaa40L/S expressing)
HCT 116 cells were metabolically labeled for 8 h with 50 or 100 µM azidomyristate or left untreated (-). Besides the well
characterized NMT substrates PRKACA and c-Src, a specific enrichment of hNaa40L could be observed in the eluates
(lanes 5) obtained by streptavidin-aided affinity purification in case of the azidomyristate treated samples (middle and right
panels). Tubulin-α (TUBA) served as negative control and * indicates a non-specific loading control. 1 to 5 correspond to
equivalents of the input lysate, clicked lysate, clicked + precipitated lysate, supernatant after streptavidin pull-down and
eluate, respectively.
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By exploiting the biotin moiety of the alkyne-functionalized biotin used, selective
enrichment of labeled proteins was performed. Although the negative control protein
Tubulin-α (TUBA) remained unlabeled as demonstrated from the lack of TUBA signal
in the respective eluates (lanes 5 in 50 and 100 µM Myr setups in Figure 7), the well
characterized NMT substrates, being it the catalytic subunit of protein kinase A (PKA)
PRKACA (cAMP-dependent protein kinase catalytic subunit alpha) [39] and the proto-
oncogene tyrosine-protein kinase Src (i.e., cellular Src or c-Src) [35] were enriched by
streptavidin-aided affinity purification in the azidomyristate treated samples (Figure 7). As
such, we assessed the myristoylation status of transiently expressed hNaa40p and found
that while hNaa40S remained unlabeled (i.e., hNaa40L was exclusively detected in the
respective eluates), hNaa40L was identified as being N-myristoylated and thus univocally
identified as being an NMT substrate (Figure 7).
As in humans, myristoylation is catalyzed by NMT1 and NMT2 [40], it is noteworthy
that NMT1 was identified as a hNaa40L specific interaction partner using biotin-dependent
proximity labeling (BioID) (see below). Combined, these results indicate that hNaa40L
represents an NMT1 substrate. Furthermore, since the N-terminus of NMT1 is thought to
mediate ribosome interactions [40] we hypothesize that Nt-myristoylation of hNaa40L by
NMT1 occurs cotranslational.
2.7. Interactomics Profiling of hNaa40p Proteoforms by Proximity-Dependent Biotin
Identification (BioID)
To study the subcellular localization of hNaa40p proteoforms in more detail and
to unravel some of the (differential) proteins they interact with and consequently infer
different hNaa40p proteoform functionalities, we applied proximity-dependent biotin
identification or BioID (Figure 8).
For this purpose, a Flag-tagged version of the promiscuous biotin ligase protein BirA*
was cloned in frame to the C-terminus of hNaa40L(dTIS>CTC) (permitting only hNaa40L
expression) or hNaa40S in a doxycycline-inducible expression vector. Since it has pre-
viously been reported that the eGFP-BirA* fusion protein localizes to both the nucleus
and cytoplasm [41], eGFP-BirA* was used as an appropriate reference for promiscuous
and non-specific protein labeling by BirA* in both the nuclear and cytosolic compart-
ments (Figure 8A). After recombination-assisted stable integration into Flp-In T-REx
293 cells, stable inducible cell lines were created and doxycycline-induced expression
and (auto-)biotinylation of BirA* fused proteoforms and eGFP verified by Western blot
analysis (Figure 8). For biotin labeling of proximal proteins, cell cultures were supple-
mented with biotin for 24h. To limit overexpression effects and for comparable bait
expression, optimized (low) doxycycline levels were chosen (experimental procedures and
data not shown) (Figure 8B). Following labeling, biotinylated proteins were isolated using
streptavidin agarose purification (Figure 8A). Silver staining of the streptavidin bound
fraction, indicated a change in the specificity of biotinylation between eGFP-BirA* and
the hNaa40p-BirA* setups (Figure 8C). Streptavidin bound proteins were subsequently
analyzed by quantitative mass spectrometry (MS) (experimental procedures). To enable
relative interactome comparisons, label-free quantification was performed by use of the
intensity values (LFQ) obtained using the MaxLFQ algorithm [42]. After log2 transforma-
tion of the obtained LFQ values, correlation (Pearson) and principal component analysis
(PCA) indicated high correlation and clustering among replicate samples while indicating
the variability between the different BioID setups analyzed (Figure 9). A multiple analysis
of variance (ANOVA) test was performed to reveal (differential) hNaa40p proteoform
interactors (p ≤ 0.01). The intensities of differential interactors are shown as heat maps
after z-score transformation and non-supervised hierarchical row clustering (Figure 10A).
Interestingly, of the previously identified binary hNaa40p interactors [43] (i.e., the hNaa40p
substrates; histone H4 and macro-H2A.1, the basic transcription factor BTF3 and its 62%
identical BTF3 paralog BTF3L4), all 4 interactors were significantly enriched with a thresh-
old p value of 0.01 in the hNaa40L(dTIS>CTC) setup, indicative of their (specific) interaction
with hNaa40L (Table S1 and Figure 10A). As mentioned above, NMT1 was over 10-fold
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enriched in the hNaa40L(dTIS>CTC) versus the Naa40S setup, indicating that NMT1 is the
likely N-myristoyltransferase of hNaa40L.
Figure 8. Proximity-dependent biotin identification (BiolD) for the discovery of differen-
tial hNaa40p proteoform interactors in Flp-In T-REx 293 cells. (A) Overview of the BiolD
(setups) and MS analysis workflow. Biological replicate samples were prepared for all 3 se-
tups analyzed (i.e., biological replicate samples of stable cell lines with doxycycline (DOX)
induced expression of eGFP, hNaa40L and hNaa40S BirA* fusion proteins) (B) Western blot
analysis showing expression and (partial) biotinylation of hNaa40L and hNaa40S BirA*
fusion proteins, and specific enrichment of biotinylated hNaa40p proteoforms following
streptavidin affinity capture. TL = total lysate, U = unbound fraction and B = bound
fraction. Purple, light blue and green arrows indicate hNaa40L, hNaa40S and eGFP-BirA*
fusion proteins, respectively. The equivalents protein input of 50 and 200 µg ‘TL’ was
analyzed for ‘TL’ and ’U’, and ‘B’ fractions, respectively. (C) Silver staining of biotinylated
proteins following streptavidin purification (representative gel is shown). ~1.5% of total
eluate sample corresponding to the input material of ~106 cells was analyzed.
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Figure 9. Heat map visualization of pairwise LFQ correlations (Pearson) (A) and PCA (B) plot of the variability between
the different setups and replicate BioID samples analyzed. Green, blue and orange indicate eGFP, hNaa40L(dTIS>CTC)
(in A. shortly referred to as hNaa40L) and hNaa40S setups, respectively.
Figure 10. Proximity-dependent biotin identification (BiolD) enables the discovery of differential hNaa40p proteoform
interactors. (A) Heat map representation of cluster analysis after ANOVA. The intensities of proteins with significantly
different abundance (p ≤ 0.01) in the respective interactomes (#937) are represented. Two clusters (cluster 1 and 2) enriched
for hNaa40L and Naa40S interactors can be observed. Green indicates low intensities while red indicates high intensities.
(B) Profile plots of representative protein categories with significant increased abundance (false discovery rate (FDR) < 2%)
in the hNaa40L(dTIS>CTC) (middle panel) and hNaa40S (right panel) setups are shown for the two indicated clusters (see also
Table S1) across all replicate samples and setups analyzed.
When specifically comparing the hNaa40L(dTIS>CTC) and Naa40S setups for the relative
enrichment of gene annotations (UniProt keywords, GOCC (Gene Ontology Cellular Com-
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ponent), GOBP (Gene Ontology Biological Process) and GOMF (Gene Ontology Molecular
Function) names, and CORUM complexes), 1D annotation enrichment analysis [44] pointed
to the respective enrichment of nuclear and cytoplasmic proteins in the hNaa40L(dTIS>CTC)
and Naa40S setups, respectively, matching the differential subcellular localizations of
the two hNaa40p proteoforms observed. Furthermore, while hNaa40L(dTIS>CTC) enriched
annotations p ≤ 0.02) encompassed ‘ribosome biogenesis’, ‘ribonucleoprotein binding’,
‘RNA-dependent ATPase activity’ and ‘nucleolus’, hNaa40S interactors were among others
significantly enriched (p ≤ 0.02) for ribosomal protein, redox-active center containing
proteins and proteins implicated in translation or fatty acid biosynthesis (Table S2 and
Figure 10B). As such, proximal proteins and thus putative interactors of the long and
short proteoform of hNaa40p match dedicated subcellular and thus segregated molecular
functions such as ribosome biogenesis, translation and fatty acid synthesis where hNaa40p
has all previously been shown to play a role in.
3. Discussion
The expression of multiple molecular forms of proteins (proteoforms) from a single
gene, particularly driven by alternative translation initiation, has only recently been ac-
knowledged to serve as a critical contributor in shaping translational landscapes across
all kingdoms of life [21,45]. Although our original study on N-terminal proteoforms re-
ported over 1500 N-termini pointing to translation initiation at dTIS, this source of protein
diversity remains vastly uncharted. Data from the few functionally characterized proteo-
forms however suggest that alternative Nt-proteoforms may very likely display differential
functions besides altered (sub-)cellular localizations or stability [45,46].
With this study, we set out to functionally characterize the newly identified shorter
proteoform of the human N-alpha acetyltransferase Naa40p, hNaa40S, explaining the
previously observed lower molecular 25 kDa weight band when probing for endogenous
Naa40p [14]. Viewing diverging N-terminal Naa40p sequences, the presence of possi-
ble NAA40 dTIS in other species such as Saccharomyces cerevisiae, Drosophila melanogaster
and plant is less clear. Interestingly, in case of Arabidopsis thaliana Naa40p (At1g18335),
N-terminal peptide evidence (Ac-MDLKKR) was found in the N-terdb database
(n-terdb.i2bc.paris-saclay.fr) matching the expression of an Nt-acetylated AtNaa40pS prote-
oform starting at AA position 28.
Interestingly, while both the canonical and short hNaa40p proteoforms exhibit indis-
tinguishable enzymatic activity, hNaa40L and hNaa40S display a differential subcellular
localization. Although the Human Protein Atlas originally reported that hNaa40p re-
sides in nuclear bodies in case of A-431 and U2 OS cells, hNaa40p localization was more
recently updated to nucleoplasm, with additional localizations to the cytosol and the
centriolar satellite (https://www.proteinatlas.org/ENSG00000110583-NAA40, accessed
on 1 December 2020). In our study, we observed that the dual subcellular localization
pattern of Naa40p previously reported in mice and human can (in part) be explained by
the differential subcellular localization of two Naa40 proteoforms expressed.
Interestingly, and in analogy, besides the previous report on differentially localized
hNaa30p isoforms raised upon alternative splicing [47], a differential subcellular local-
ization and stability was previously also reported in the specific case of mouse Naa10p
isoforms differing at their C-terminus and with mNaa10pS being an alternative splicing
isoform specific to mouse found to be differentially regulated [48].
Moreover, we demonstrated that the N-terminal extension of hNaa40pL—which har-
bors a putative nucleolar localization sequence (NoLS) and which can be
Nt-myristoylated—likely explains the predominant nuclear/nucleolar localization of
hNaa40L. Interestingly, the N-terminus of AtNaa40pL holds a ChloroP predicted chloro-
plast transit sequence (aa1-26) [49] and the subcellular localization database for Arabidopsis
proteins (SUBA4) also predicts a nuclear localization of AtNaa40p [50], indicating that At-
Naa40p proteoforms of which note above likely display differential subcellular localizations.
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Furthermore, the unique extra helix-loop-strand secondary structural element con-
tained within the N-terminal segment of hNaa40p implicated in substrate binding and sta-
bility maintenance, is contained within both hNaa40 proteoforms as it comprises residues
24–51 of full-length hNaa40p [11]. However it is important to note that the first 16 and
last 17 amino acid residues of full-length hNaa40p which fall outside the ~150 residue core
of high sequence conservation but which are respectively highly enriched in positively
charged Lys/Arg, and His residues, were not present in the recombinant hNaa40 variant
(i.e., hNaa40, residues 17–220) used for structural determination [11]. Therefore, if and
how these terminal sequences may affect stability, substrate accessibility or binding is
currently not known. Since we observed that C-terminal His-tagging of Naa40p resulted
in a somewhat less outspoken subcellular segregation of hNaa40p proteoform localiza-
tion (data not shown) it is conceivable that the C-terminal sequence might also impact
hNaa40p localization.
Besides the proteoform-specific subcellular localization of hNaa40p proteoforms,
differential expression of these proteoforms upon cellular differentiation could also be
demonstrated. Viewing the aberrant and highly variable NAA40 expression observed in
a variety of cancers [15], expression profiling at the level of proteoforms thus appears a
prerequisite to further unravel the (distinct) roles of Naa40p proteoforms in disease.
Furthermore, with only histone H4 and H2A proteins being reported as Naa40p
substrates, we here expanded on the Naa40p substrate repertoire by the identification of
yH2A.Z (SGKA) and the transcriptional regulatory protein Lge1 (SGYT) as endogenous
yNaa40p and redundant yNaa40p/yNatA substrates, respectively. Furthermore, since
we previously observed that only the Nt-acetylated counterpart of a synthetic histone
H4 Nt-peptide was refractory towards hNaa40p mediated N-acetylation [14], hNaa40p
acetylates the α-amino group of H4 and (not significantly) any of the lysine residues known
to be Nε-acetylated by lysine acetyltransferases. Moreover, structural data revealed the
striking divergent feature of Naa40p being the presence of occluding loops preventing
internal lysines from inserting into the active site, providing a molecular basis for specific
amino-terminal acetylation by Naa40p [11]. Altogether, the lack of N-free H4 and H2A.Z
can thus be attributed to these Naa40p substrates being (at least partially) Nt-acetylated in
the y[hNAA40] and y[hNAA40S] setups analyzed.
Although the from yeast to human conserved yH2A.Z and yH2A histones share 61%
identity, yH2A.Z contains additional N- and C-terminal amino acids and comprises roughly
10% of the total cellular H2A which is almost exclusively incorporated at transcription
start sites. Although not directly participating in the activation of transcription, H2A.Z
seems to play a role in preventing DNA-methylation dependent chromatin silencing and
chromatin accessibility [51].
Next to Lge1, we previously reported 3 other putative redundant yNaa40p/yNatA
substrates Scl1 (SGAA), Ypi1 (SGNQ) and Dph1 (SGST). More specifically, their correspond-
ing SG- starting N-termini also remained (partially) Nt-acetylated in yeast deleted for
yNatA [17], an observation in line with Lge1, and H2A and H4 being Nt-acetylated in the
same yeast background. Considering all 7 (highly likely) yNaa40p substrates, it is apparent
that the consensus N-terminal sequence deviates from the P1′-P4′ SGSR consensus hNaa40p
substrate specificity determined by proteome-derived peptide library screening [14] and
structural analysis of Schizosaccharomyces pombe Naa40p (SpNaa40p) and hNaa40p bound to
an H4/H2A N-terminal substrate [11]. More specifically, the yNaa40p substrate specificity
appears confined to the P1′ and P2′ amino acids SG- viewing the divergence observed at
P3′-P4′, thus indicating that the substrate specificity of yNaa40p is less extended when com-
pared to hNaa40p and SpNaa40p substrate specificities, and that scNaa40p likely evolved
to accommodate N-termini with varying P3′ and P4′ specificities. This observation is also
in line with yH2A (SGGK) representing a yNaa40p-only substrate as yH2A is refractory
towards hNaa40p mediated Nt-acetylation when ectopically expressed in yeast [14], a find-
ing in contrast with yH4 (SGRG) representing a human and yeast Naa40p substrate [14].
Structural analysis of scNaa40p bound to an N-terminal substrate would potentially reveal
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structural differences in substrate recognition and differences in the extended substrate
specificity profiles of orthologs Naa40p.
In addition to the Naa40p substrates of which note, H2A.X and SMARCD2 were also
put forward as two putative hNaa40p substrates based on their SGRG- N-termini matching
the Naa40p consensus substrate specificity [11]. In this context, it is interesting to note
that our differential interactomics data obtained by BioID identified several known compo-
nents of the multiprotein chromatin-remodeling SWI/SNF and related complexes—and
thus known SMARCD2 interactors—(e.g., the catalytic subunits SMARCA4, SMARCA5,
SMARCE1 and SIN3A) as significantly enriched in the proxeome of hNaa40L. Furthermore,
and besides the known substrate histone H4, the core histone macro-H2A.1 (SSRG-) was
also identified in the hNaa40L interactome. Overall, our data indicates that known and
putative hNaa40p substrates are specifically enriched in the interactome of nuclear local-
ized hNaa40L, again pointing to possible post-translational nuclear Nt-acetylating activity
of hNaa40L over these (putative) substrates. However, it cannot be excluded that a small
cytosolic resident fraction of hNaa40L may also contribute to cytosolic hNaa40p activities.
BioID also further refined putative proteoform-specific roles of hNaa40p. As deduced
from their respective interactomes, hNaa40S likely represents the main co-translationally
acting actor, while in line with its N-terminal extension holding a nucleolar localization
signal, the hNaa40L interactome was enriched for nucleolar proteins implicated in ribo-
some biogenesis and the assembly of ribonucleoprotein particles. Overall, our BioID data
indicates a proteoform-specific segregation of previously reported Naa40p activities.
To create a selective hNAA40L knockout HAP1 clone, a guide RNA was designed to
target exon 2 in the region preceding the dTIS. Since the effectiveness of gene deletions is
frequently assessed at the gene level, it is striking that in roughly one third of the attempts to
knock out genes via CRISPR-Cas9-induced frameshift mutations, translation products are
still produced due to alternative splicing events skipping the CRISPR-induced frameshift
or to translation initiation at a dTIS not impacted by the mutation [52]. The observed
expression of residual hNaa40S in the hNAA40L line and our previous results on observed
METAP2 activity in a so-called METAP2 knockout line [53], are in line with the afore-
mentioned study and indicates that besides the creation of full knockouts, CRISPR-Cas9
induced frameshifts can result in the expression of truncated proteoforms with (partially)
preserved protein function. These observations warrant caution when determining gene
essentiality based on CRISPR-Cas9 targetability and thus necessitating phenotypic inter-
rogation of lines generated by CRISPR-Cas9. In the specific case of hNAA40, inspection
of the hNAA40L- HAP1 line demonstrated that while the frameshift permitted hNaa40S
proteoform expression in the hNAA40L background, residual hNaa40S was deficient in pre-
serving histone H4 Nt-acetylation capacity indicating that either the remaining hNaa40pS
expression levels were too low or alternatively, hNaa40L is mandatory for (nuclear) histone
H4 Nt-acetylation.
4. Materials and Methods
4.1. Cell Culture
The human HCT 116 colon cancer cell line was kindly provided to us by the Johns
Hopkins Sidney Kimmel Comprehensive Cancer Center (Baltimore, BAL, MD, USA) and
cultivated in McCoy’s medium (Gibco™, Thermo Fisher Scientific Inc., Waltham, MA, USA,
cat n◦22330-021). K-562 (ATCC, American Type Culture Collection, Manassas, VA, USA;
CCL-243) and HL-60 (ATCC, CCL-240) cells were grown in RPMI 1640 medium (In-
vitrogen, Life technologies, Waltham, MA, USA, cat n◦61870-044). Human A-431 (epi-
dermoid carcinoma; American Type Culture Collection (ATCC), Manassas, VA, USA;
ATCC® CRL-1555™), Human HeLa cells (epithelial cervix adenocarcinoma, American
Type Culture Collection, Manassas, VA, USA; ATCC® CCL-2™) and Flp-In™ T-REx™-
293 cells (Thermo Fisher Scientific) were cultured in GlutaMAX containing Dulbecco’s
Modified Eagle Medium (DMEM) (Invitrogen, cat n◦31966047). The HAP1 wild type and
CRISPR/Cas9 edited human knockout cell lines obtained from Horizon Genomics GmbH
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(Vienna, Austria) were grown in Iscove’s Modified Dulbecco’s Medium (IMDM) (Invitro-
gen, cat n◦31980-048). More specifically, two hNAA40 knockout clones (i.e., a hNAA40-4bp
deletion knock out (HZGH C003224c001 (clone 1) and HZGHC003224c012 (clone 2)) con-
taining a frameshift mutation in hNAA40 were obtained (i.e., hNAA40 knockout HAP1
clones carrying a 4bp deletion in the second coding exon of NM_024771 at genomic loca-
tion chr11:63945863 were created using the guide RNA sequence GAAGAACAGAAGCG-
GTTGG leading to the corresponding hNAA40 genomic sequence of GGAGAAGAAGCA-
GAAGCGGT(TGGA insertion)GGAGCGAGCAGCCATGGATG which was sequence veri-
fied by RNA-seq and Sanger sequencing (data not shown) upon PCR amplification from
purified genomic DNA using the following primers; CTCTTTCTGAAGGGAAGCTGA-
GAAG (forward) and TTATAAACCAAGCTGAAGTCCCAGG (reverse) and sequencing
primer CTCTTTCTGAAGGGAAGCTGAGAAG).
All media contained 2 mM alanyl-L-glutamine dipeptide (GlutaMAX™) and were
supplemented with 10% fetal bovine serum (FBS) (HyClone, Gibco™, cat n◦10270106,
E.U.-approved, South American origin), 50 units/mL penicillin (Gibco™, cat n◦15070-063)
and 50 µg/mL streptomycin (Gibco™, cat n◦15070-063). Parent Flp-In™ T-REx™-293 cells
were additionally supplemented with 15 µg/mL blasticidin (InvivoGen, cat n◦ant-bl-1)
and 100 µg/mL zeocin for cultivation, while zeocin was added at 800 µg/mL for counter
selection of stable transfected cells (InvivoGen, cat n◦ant-zn1). Stable transformants were
maintained in media supplemented with blasticidin and 50 µg/mL Hygromycin B Gold
(InvivoGen, cat n◦ant-hg-1).
For L-Arg SILAC (stable isotope-labeling by amino acids in cell culture) labeling of
K-562 cells, cells were grown in RPMI 1640 SILAC medium (Invitrogen, cat n◦61870-010)
containing either natural, 13C6- or 13C615N4-labeled L-Arg (Cambridge Isotope Laborato-
ries, Andover, MA, USA) [24] at a concentration of 57.5 µM (5% of the suggested concen-
tration in RPMI 1640 medium) and media were supplemented with 10% dialyzed fetal
bovine serum (Invitrogen, cat n◦26400-044). Cell populations were cultured for at least six
population doublings for complete incorporation of the labeled L-Arg.
K-562 cells were induced to differentiate into megakaryocytes at a density of 3 × 105
cells per ml using 40 nM PMA (Sigma-Aldrich, St. Louis, MO, USA) and collected at
the indicated time points after induction. Light microscopic inspection of cell morphol-
ogy to monitor cellular differentiation was performed on an Axiovert 25 microscope
(Carl Zeiss, Jena, Germany).
All cells were cultured at 37 ◦C in a humidified incubator at 37 ◦C and 5% CO2 or 8%
CO2 and passaged every 3–4 days.
4.2. Bacterial Strains
For cloning, Escherichia coli strains DH5α, DH10B or Top10 were used using standard
chemical transformation protocols.
4.3. N-Terminal Proteomics
PMA treatment of L-Arg SILAC labeled K-562 cells proceeded for 4 or 6 days with
40 nM of PMA. Control cells were harvested on the day of PMA treatment initiation. Cells
that became adherent during the differentiation process were detached using cell dissocia-
tion buffer (Invitrogen, cat n◦13151014) and pooled with non-adherent cells. The obtained
cell pellets (20× 106 cells) were washed twice in phosphate-buffered saline (PBS) and lysed
in 1 mL of 50 mM HEPES pH 7.4, 100 mM NaCl, 0.8% CHAPS with a cOmplete™ protease
inhibitor cocktail tablet added (Roche, cat n◦11697498001) for 10 min on ice and centrifuged
for 15 min at 16,000× g at 4 ◦C. Subsequently, the cleared lysates were subjected to N-
terminal COFRADIC analysis as described previously [26] where in vitro 3C2D3-acetylation
(using NHS (N-hydroxysuccimide) 13C2D3-acetate) was performed at the protein level
to discriminate between in vivo free and in vivo Nt-acetylated protein N-termini, further
enabling calculation of the extent of in vivo Nt-acetylation [54]. Differential L-Arg SILAC
labeling moreover enables the relative quantification of Nt-peptide abundancy [25,26].
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4.4. Generation of TIS Mutagenized hNAA40 and Flag-Tagged hNaa40p Expressing Constructs
A sequence-verified full-length I.M.A.G.E. cDNA clone of hNAA40 (matching mRNA
gi:13376118, cDNA clone MGC:59726, IMAGE:6292760)) cloned in the pOTB7 vector
(IRAUp969D10104D, RZPD Imagenes, Germany) served as template for site-directed PCR-
mutagenesis (QuickChange, Stratagene, La Jolla, CA, USA) according to the manufacturer’s
instructions and as described in [55] and using the primer pairs (10 nmol, RP-cartridge
Gold, Eurogentec) Naa40a120c forward: 5′-GGAGCGAGCAGCCCTGGATGCCGTTTG-3′
and Naa40a120c reverse: 5′-CAAACGGCATCCAGGGCTGCTCGCTCC-3′ to introduce
an ATG to CTG mutation of the newly identified dTIS in the coding sequence of hNAA40,
concomitantly resulting in recoding of Met22 to Leu.
pMET7 Flag-tagged hNaa40p expressing constructs encoding either wild type full-
length and thus also potential short hNaa40p (hNaa40L/S), hNaa40p with mutation of
the dTIS (hNaa40L(dTIS>CTG)) or mutation of the dbTIS (hNaa40S(dbTIS>CTG)), in addition
to the shorter hNaa40S coding sequence (CDS) were generated using standard ApaI and
SalI-HF restriction cloning and ligation. The following PCR primer pairs were used to
introduce the ApaI and SalI restriction sites (underlined sequence), wt. or mutagenized
TIS (bold) and to amplify hNAA40L/S from the wild type hNAA40 sequence (ApaI forward:
5′-GCGAGGGCCCAGCTTATGGGGAGAAAGTCAAGC-3′), hNAA40L/(dTIS>CTG) from
dTIS > CTG mutagenized NAA40 sequence (ApaI forward: 5′- -3′), hNAA40 S(dbTIS>CTG)
from the wild type hNAA40 sequence (ApaI forward: 5′-GCGAGGGCCCAGCTTCTCGGG
AGAAAGTCAAGC-3′), hNAA40S from the wild type hNAA40 sequence (ApaI forward:
5′- GCGA GGGCCCAGCTTATGGATGCCGTTTGTGCC-3′) and all PCRs using the SalI
primer 5′- GCGAGTCGACGTGGCAGCAGCCACC-3′ as reverse primer. The correctness
of all (mutant) cDNA sequences was confirmed by Sanger sequencing.
4.5. Coupled In Vitro Transcription and Translation Assay
hNAA40 and dTIS mutagenized hNAA40 pOTB7 constructs were used as templates
for in vitro coupled transcription/translation in a rabbit reticulocyte lysate system accord-
ing to the manufacturer’s instructions (Promega, Madison, WI, USA) to generate [35S]
methionine labeled translation products. 5 µL of the translate reaction was diluted 10-fold
in 10 mM Tris pH 8.0. NuPAGE® LDS Sample Buffer (Invitrogen, Cat n◦NP0007) was
added and the samples heated for 10 min at 70 ◦C. Samples were separated on 4–12%
NuPAGE® Bis-Tris gradient gels (1.0 mm × 12 well) (Invitrogen, Cat n◦NP0321) using
MOPS SDS Running Buffer (Invitrogen, Cat n◦NP0001). Subsequently, proteins were
transferred onto a polyvinylidene fluoride (PVDF) membrane, air-dried and exposed to a
film suitable for radiographic detection (ECL (enhanced chemiluminescence) Hyperfilms,
Amersham Biosciences, Buckinghamshire, UK) and radiolabeled proteins were visualized
by radiography.
4.6. Yeast Cultivation and Strain Generation
Yeast was cultivated according to standard procedures. An N-terminal truncated
hNAA40 expression construct was made by subcloning the CDS part encoding hNAA40S
from the I.M.A.G.E. cDNA clone (see above) to the pBEVY-U S. cerevisiae expression vector
with bidirectional promoter using XmaI and EcoRI restriction cloning. The following
PCR primer pair was used to introduce the XmaI and EcoRI restriction sites (underlined
sequence) and to amplify hNAA40S; hNAA40S XmaI forward: 5′-GATCATCCCGGGCG
CTATGGATGCCGTTTGTGCC-3′ and hNAA40S EcoRI reverse: 5′-GATCATGAATTCTCA
GTGGCAGCAGCCACCAC-3′. The correctness of the construct was confirmed by Sanger
sequencing. pBEVY-U-hNAA40 [14] and pBEVY-U-hNAA40S expression vectors were
introduced in the ynaa40∆ S. cerevisiae (Y16202) MAT alpha strain (Euroscarf) (ynaa40∆), to
generate a y[hNAA40] and y[hNAA40S] strain. To generate a control yeast strain pBEVY-U
was introduced in the S. cerevisiae BY4742 (Y10000) WT MAT alpha strain [14]. Selection of
transformed strains was performed on plates lacking uracil.
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4.7. Histone Extraction Followed by In-Gel Stable-Isotope Labeling (ISIL) and In-Gel Digestion
For histone isolation, the equivalent of one 10 cm subconfluent HAP1 dish or alterna-
tively an 80 mL yeast culture cultivated in Synthetic Defined (SD) Yeast medium lacking
uracil (Sigma) to an OD600 of ~5.5–6.0 were used as input samples for performing histone
extraction. Cell pellets collected by centrifugation (5 min at 1500× g) were resuspended in
3 mL (yeast) or 500 µL lysis buffer (0.2% TRITON-X-100, 10 mM HEPES (pH 7.6), 1.5 mM
MgCl2, 10 mM KCl, 1 mM sodium orthovanadate, 10 mM sodiumbutyrate, 20mM β-
glycerophosphate and a cOmplete™ ethylenediaminetetraacetic acid (EDTA) free protease
inhibitor cocktail tablet added (Roche, cat n◦11873580001). In case of HAP1 lysates, the
lysates were left on ice for 10′ and centrifuged at 3000× g (4 ◦C) and the pellets kept for
subsequent histone extraction (see below). For all yeast samples, an equal volume of
0.5 mm glass beads was added to the suspensions for 10 rounds of vortexing (30 s) and
cooling on ice (30 s). After lysis, the glass beads were removed by centrifugation for 5 min.
at 3000× g and 4 ◦C and the cleared supernatant was centrifuged for 10 min. at 10,000× g
and 4 ◦C and kept for Western blot analysis (see below). Pellets obtained in case of yeast
and HAP1 samples were washed in lysis buffer followed by centrifugation for 5 min at
3000× g. The pellets were incubated in 450 µL (yeast) or 150 µL (HAP1) 0.4 M HCl for 1 h
and centrifuged for 15 min. at 13,000× g. 6 volumes of cold aceton (−20 ◦C) were added to
the supernatant, vortexed and acid-extracted proteins precipitated overnight at −20 ◦C.
After centrifugation for 15 min. at 13,000× g, and 3 rounds of washing with cold aceton,
the pellets were dried for 5 min in a vacuum concentrator. The dried pellets enriched for
histones were dissolved in sample buffer (8 M urea, 5% β-mercaptoethanol and 10 mM
Tris-HCl (pH 7.0)) and added sample loading buffer (Bio-Rad XT sample buffer, Bio-Rad
Munich, Germany). The samples were separated on a 12% on a 12% gradient XT precast Cri-
terion gel using XT-MOPS buffer (Bio-Rad) using XT-MOPS buffer (Bio-Rad) at 150–200 V.
Coomassie-stained histone bands were cut from the gel, followed by in-gel-stable isotope
labeling (ISIL) making use of N-hydroxysuccimide (NHS) 13C2D3-acetate and in-gel protein
digestion (i.e., a 30 min. and 2 h. digestion at 37◦C)as described previously [14,30]. The
resulting peptide mixtures were acidified (0.1% formic acid) and analyzed by LC-MS/MS
analysis as described previously [14].
4.8. Metabolic Labeling Using 12-Azidododecanoic Acid to Assess the N-Myristoylation Status of
Transiently Expressed hNaa40p Proteoforms
Human HCT 116 cells seeded one day prior to transfection at 5.8 (in case of 24 h
azidomyristate labeling) or 7.5 (8 h azidomyristate labeling) × 106 cells/per 10 cm plate in
8 mL DMEM without FBS, were transiently transfected for 24 h with 9.36 µg of hNAA40-
flag expression vectors and using 35 µL Fugene HD (Roche, cat. n◦04709705001) according
to the manufacturer’s instructions. More specifically, DNA/transfection reagent complexes
in 500 µL Opti-MEM (Invitrogen, cat n◦51985-042) were allowed to form by mixing and
incubation at room temperature for 10 min. Medium was replaced with 5ml Opti-MEM
and the DNA complexes (545 µL ) were added to the medium by gently mixing. Cells were
incubated at 37 ◦C and 5% CO2. After 4 h of transfection, 1100 µL 50% FCS containing
DMEM was added to bring to a f.c. of 10% FCS and incubated at 37 ◦C and 5% CO2. 24 h
post-transfection, the medium was replaced with 5 mL fresh medium and 50 or 100 µM
12-azidodo-decanoate (azidomyristate) (Click-IT™ Myristic Acid, Azide, ThermoFisher
Scientific, Cat n◦ C10268) in dimethyl sulfoxide (DMSO) or vehicle was added to the
media and incubated for an extra 8 or 24 h as indicated. The cells were washed with
cold PBS, harvested in PBS by scraping, and lysed for 10′ on ice by resuspension of the
cell pellets in 1 mL of lysis buffer (1% SDS in PBS) and 5′ of vortexing, followed by
centrifugation of the lysates at 16,000× g (10 min at 4 ◦C) and collection of the cleared
supernatant. Protein concentration of the supernatant was determined using the Bio-Rad
DC Protein Assay according to the manufacturer’s instructions. Protein concentrations
were adjusted to 600 µg/mL with lysis buffer and per sample and the CuAAC reaction
performed essentially as described in [56].
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In brief, a click mixture for CuAAC was prepared by the ordered addition and inter-
mittent vortexing between each addition of; alkyn-biotin conjugate (PEG4 carboxamide-
Propargyl Biotin, Invitrogen, Cat n◦ B10185), 14 µL of 5 mM stock solution DMSO, final
concentration 0.0875 mM), CuSO4 (28 µL , stock solution 50 mM in DMSO, final concen-
tration 1.75 mM) and tris(benzyltriazolylmethyl)amine (TBTA) (28 µL , stock solution 5
mM in DMSO, final concentration 0.175 mM). The click mixture (70 µL ) was added to each
sample to 700 µL of lysate (420 µg of protein), mixed, and sodium ascorbate additionally
added (28 µL , stock solution 50 mM, final concentration 1.75 mM). The reaction mixture
was left at room temperature (RT) for 1 h. Next, 7 mL ice-cold MeOH and EDTA (final
concentration 10 mM) were added to each sample, vortexed and precipitated overnight at
−80 ◦C. After overnight precipitation, the samples were centrifuged at 16,000× g (30 min
at 4 ◦C) and the obtained protein pellets washed with 1 mL ice-cold MeOH and dried.
For enrichment of myristoylated proteins, pellets were resuspended in 2% SDS in
PBS, 10 mM EDTA (140 µL ). Once the pellet was completely dissolved, 560 µL of PBS
was added (0.4% SDS f.c.). 100 µL was served as ‘input’ sample. The remaining was
diluted to 0.2% SDS by the addition of 600 µL PBS. Dynabeads MyOne Streptavidin C1
(80 µL ) (ThermoFisher Scientific, cat n◦65601) washed 3 times with 1 mL 0.2% SDS in PBS
were added to the sample and gently vortexed for 90 min. The supernatant was removed
(unbound fraction) and the beads were washed 3 times with 0.2% SDS (3 × 1000 µL ).
120 µL of 2% SDS in PBS, 42 µL 4× Bio-Rad XT sample loading buffer and 8.5 µL 20×
Bio-Rad XT reducing agent were added to the beads and boiled for 5 min. Samples were
centrifuged at 1000× g for 2 min and loaded on an SDS–polyacrylamide gel electrophoresis
gel (‘before pull-down’ sample: 20 µL ; supernatant: 20 µL pull-down: 20 µL (5*more).
Elution fractions after streptavidin purification were centrifuged at 1000× g for 2 min.
10 µg protein (input/unbound) and the equivalent of 50 µg protein input (elution) were
analyzed on a 4–12% gradient XT precast Criterion gel using XT-MOPS buffer (Bio-Rad).
4.9. Total Cell Lysis, Cytoplasmic and Nuclear Fractionation
A-431 cells were transiently hNAA40-flag transfected for 24 h with hNAA40-flag ex-
pression vector and using Fugene HD (Roche) according to the manufacturer’s instructions
and as described above. Cells were harvested by trypsin-EDTA or scraping in D-PBS with-
out Ca2+ and Mg+ and collected by centrifugation for 5′ at 600× g at 4◦C. The cell pellets
were washed in ice-cold D-PBS, re-centrifuged and resuspended at ~5 × 106 cells/mL in
either lysis buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% NP-40) by repeated freezing
and thawing for obtaining total lysates (TL) or alternatively, for cytoplasmic and nuclear
fractionation in buffer A containing 10 mM HEPES, pH7.5, 10 mM KCl, 1 mM MgCl2, 5%
glycerol, 0.5 mM EDTA, 0.1 mM EGTA supplemented with 0.5 mM DTT, 2 mM Pefablock
and 0.15 U/mL aprotinin. For total lysates (TL), lysis was allowed to proceed for 15′ on ice
and the supernatants collected after centrifugation for 10′ at 10,000× g. For cytoplasmic
and nuclear fractionation, cell suspensions were left to swell for 15′ on ice in buffer A.
Thereafter, NP-40 was added to a final concentration of 0.65% (v/v) and the cells lysed by
vortexing for 10 s. Remaining intact nuclei were pelleted by centrifugation for 10′ at 700× g,
the supernatant collected (cytoplasmic fraction (C)) collected and the nuclear-enriched
fractions re-centrifuged at higher speed (5′ at 5000× g) for complete removal of residual
buffer A, and followed by two washes in buffer A containing 1% NP-40. The obtained
pellets enriched for nuclei were lysed in lysis buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl,
1% NP-40) by repeated freezing and thawing. Supernatants enriched for nuclear proteins
(N) were collected by transfer of the supernatant obtained after centrifugation at 16,000× g
for 20 min at 4 ◦C. Protein concentration was performed by Bio-Rad DC Protein Assay
determination according to the manufacturer’s instructions and equal protein amounts
of cytoplasmic and nuclear fractions were analyzed for the comparison of a protein’s
cytoplasmic versus nuclear distribution within the cell.
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4.10. SDS-PAGE and Immunoblotting
Sample loading buffer (Bio-Rad XT sample buffer) and reducing agent (Bio-Rad) was
added to the samples according to the manufacturer’s instruction and equivalent amounts
of protein (30 µg as measured using the DC Protein Assay Kit (Bio-Rad) and proteins were
separated on a 4 to 12% on a 12% gradient XT precast Criterion gel using XT-MOPS buffer
(Bio-Rad) at 150–200 V. Subsequently, proteins were transferred onto a PVDF membrane.
Membranes were blocked for 30 min in a 1:1 Tris-buffered saline (TBS)/Odyssey blocking
solution (cat n◦ 927-40003, LI-COR, Lincoln, NE, USA) and probed by Western blotting.
Following overnight incubation of primary antibody in TBS-T/Odyssey blocking buffer
and three 10 min washes in TBS-T (0.1% Tween-20), membranes were incubated with
secondary antibody for 30 min in TBS-T/Odyssey blocking buffer followed by 3 washes in
TBS-T or TBS (last washing step). The following antibodies were used: mouse anti-Flag
(Sigma, F3165; 1/5000), mouse anti-GAPDH (Abcam, ab9484, 1/10,000), rabbit anti-histone
H3 (Cell Signaling, #9715, 1/2000), rabbit anti-hNaa40p/anti-nat11 (Sigma, SAB3500167,
1/1000) (polyclonal antibody raised against 15 aa at the C-terminus of hNaa40p), rabbit anti-
α-Tubulin (Cell Signaling, #2144, 1/2000), mouse anti-α-Tubulin (Sigma, T5168, 1/1000),
rabbit anti-PRKACA (Cell Signaling, #5842S, 1/2000), rabbit anti-c-Src (Cell Signaling,
#2123, 1/1000), streptavidin-Alexa Fluor™ 680 Conjugate (Invitrogen, S32358, 1/10,000),
anti-mouse (IRDye 800 CW goat anti-mouse antibody IgG, LI-COR, cat n◦ 926-32210,
1/10,000) and anti-rabbit (IRDye 800 CW goat anti-rabbit IgG, LI-COR, cat n◦ 926-3221,
1/10,000). The bands were visualized using an Odyssey infrared imaging system (LI-COR).
4.11. Generation of Stable, Inducible Expression Cell Lines of C-Terminal BirA*-Tagged
HNaa40p Proteoforms
NAA40L(dTIS>CTC) and NAA40S expressing constructs for BioID were generated via
Gateway cloning. More specifically, Flag-tagged hNAA40 L(dTIS>CTC) and hNAA40 vec-
tors served as templates to generate attB-flanked hNAA40 L(dTIS>CTC) and hNAA40S PCR
products suitable for use in a Gateway® BP recombination reaction with a donor vector
(pDONR221, Invitrogen, cat n◦12536-017) thereby creating an entry clone. Forward primers
of hNAA40L(dTIS>CTC) (5′- GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACCATGGG
GAGAAAGTCAAGCAAAGCC-3′) and hNAA40S (5′-GGGGACAAGTTTGTACAAAAA
AGCAGGCTTCACCATGGATGCCGTTTGTGCCAAAGTGGACG-3′) and the respective
reverse primer (5′-GGGGACCACTTTGTACAAGAAAGCTGGGTCGTGGCAGCAGCCAC
CACAGTG-3′) was used to generate attB-flanked PCR products. The reverse primer was
designed to fuse the desired PCR products in frame with a C-terminal BirA*-FLAG tag
encoded by the destination vector. To create hNAA40 L(dTIS>CTC) and hNAA40S expres-
sion clones, the inserts of the entry vectors were recombined into the into the pDEST
5′ BirA*-FLAG-pcDNA5-FRT-TO destination vector (Invitrogen, cat n◦12285-011) using
LR-clonase (Invitrogen, cat n◦ 11791-020) according to the manufacturer’s instructions.
All constructs were sequence verified by Sanger sequencing. Stable cell lines expressing
hNaa40L or hNaa40S proteoform bait proteins in Flp-In T-REx-293 cells that contain a stably
integrated flippase recognition target (FRT) site at a transcriptionally active genome locus
(Thermo Fischer Scientific) were generated as cell pools as described in [57]. Briefly, Flp-In
T-REx 293 cells were co-transfected with a hNAA40 L(dTIS>CTC) or hNAA40S expression
construct and the Flp recombinase encoding pOG44 plasmid (Invitrogen) in a 1:9 ratio
(in 6-well plates at 60–70% confluency) using Lipofectamine®LTX with Plus™ Reagent
(Invitrogen) in Opti-MEM according to the manufacturer’s instructions. Successful Flp-
FRT-mediated recombination of the hNAA40 inserts were selected for with 15 µg/mL
blasticidin and 50 µg/mL hygromycin B and the selection medium replaced every 2–3 days
until the appearance of visible foci. Selected cell populations were pooled thereafter by
incubation with cell dissociation buffer, collection by centrifugation (1000× g, 5 min) at 4 ◦C
and resuspension and maintenance in complete DMEM supplemented with blasticidin
and 50 µg/mL hygromycin B. (moreover Pen./Strep.) Cell pools were expanded and
grown without tetracycline. Stable cells expressing BirA*-FLAG fused to enhanced green
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fluorescent protein (eGFP) were used as negative control setup for the BioID experiments
and processed in parallel to the hNaa40p proteoform bait proteins.
4.12. BioID
For BioID, stable cell lines were plated at 1.5 × 107 cells (corresponding to 70–80%
confluence) per 100-mm plate. 6 h after plating, expression was induced by the addition
of an optimized concentration of the stable tetracycline derivative doxycycline (DOX) at
2 ng and 5 ng/mL for hNaa40p proteoform and eGFP expression, respectively, and 16 h
thereafter, 50 µM biotin was added for an extra 24 h. For BioID, per construct, six 100-mm
plates were used for harvesting. Cells were washed with D-PBS and harvested by scraping
and collection of the cells in 5 mL ice-cold PBS, followed by pelleting of the cells (in 2
aliquots containing respectively 10% and 90% of the cell material) at 600× g for 5′ at 4 ◦C.
Pellets were kept frozen at −80 ◦C until further processing.
The frozen pellets corresponding to a total of ~1 × 108 cells (90% of cell material)
were resuspended in ~7.5 mL BioID lysis buffer (100 mM Tris pH 7.5, 150 mM NaCl,
2% SDS and 8M urea) to reach a protein concentration of ~2 mg/mL (i.e., the volume
of BioID lysis buffer added was based on protein concentration determination using the
DC Protein Assay Kit from Bio-Rad on the 10% aliquot samples lysed in 50 mM Tris-HCl
pH 8.0, 150 mM NaCl and 1% NP-40). The suspensions were subjected to mechanical
disruption by 3 repetitive freeze-thaw cycles in liquid nitrogen followed by 3 sonication
cycles (i.e., 2 min of sonication on ice for 25-s bursts at output level 4 with a 40% duty
cycle (Branson Sonifier 250; Ultrasonic Convertor)). To 7.5 mL of lysate (~15 mg of protein),
a 500 µL 50% suspension of 3 times pre-washed streptavidin agarose beads (Novagen,
Cat. N◦69203) (i.e., washes were performed by repeated resuspension and pelleting of the
beads by centrifugation at 600× g for 5 min with 2 mL of high stringency buffer; 100 mM
Tris pH 7.5, 2% SDS, 8M urea and 150 mM NaCl) was added and incubated overnight at
room temperature in a rotator to capture biotinylated proteins. After overnight incubation,
the beads were pelleted (600× g, 2 min) and the unbound supernatant removed and
kept for further analysis. The beads were then extensively washed (4 times 5′ and an
additional 30′ wash with 1 mL of high stringency buffer (5 washes in total), followed
by an additional 30′ wash with high salt buffer (1M NaCl, 100 mM Tris.HCl pH 7.5), a
wash with ultrapure water (5′), and 3 × 1 mL 50 mM ammonium bicarbonate (pH 8.0)
washes (5′). Following the final wash, the beads were pelleted, and any excess liquid was
aspirated off. 90% of the beads were then resuspended in 600 µL of 50 mM ammonium
bicarbonate (pH 8.0), and 1 µg of mass spectrometry grade trypsin (Promega, Madison,
WI) was added. The samples were incubated overnight at 37 ◦C with vigorous mixing
(850 rpm) to keep the beads in suspension. After overnight digestion, an additional 0.5 µg
of trypsin was added, followed by an additional incubation of 2 h. The beads were pelleted
(600× g, 2 min) and the supernatant was transferred to a fresh low protein binding tube
(Eppendorf). The beads were washed with 2 × 300 µL HPLC (high performance liquid
chromatography) grade water and the washes combined with the original supernatant.
The peptide solution was acidified with 10% formic acid to reach a final concentration of
0.2% and cleared from insoluble particulates by centrifugation for 15 min at 16,000× g
(4 ◦C) and the supernatant transferred to clean tubes. The samples were vacuum-dried in a
SpeedVac concentrator, re-dissolved in 25 µL of 2 mM tris(2-carboxyethyl)phosphine in 2%
acetonitrile, centrifuged for 15 min at 16,000× g (4 ◦C) and transferred to clean mass spec
vial for LC-MS/MS analyses.
4.13. LC-MS/MS Analysis and Data Analysis of BioID Samples
BioID samples were analyzed by LC-MS/MS using an UltiMate 3000 RSLC nano HPLC
(Dionex) in-line connected to a Q Exactive instrument (Thermo Scientific, Bremen, Ger-
many) as previously described [58,59]. Raw data files were searched with MaxQuant [60]
using the Andromeda search engine [61] (version 1.5.3.30) and MS/MS spectra searched
against the Swiss-Prot database (taxonomy Homo sapiens) complemented with the BirA*Flag
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and eGFP sequences. Potential contaminants present in the contaminants.fasta file that
comes with MaxQuant were automatically added. A precursor mass tolerance was set
to 20 ppm for the first search (used for nonlinear mass recalibration) and set to 4.5 ppm
for the main search. As enzyme specificity, trypsin was selected and up to two missed
cleavages were allowed. Methionine oxidation and N-terminal protein acetylation were set
as variable modifications. The false discovery rate for peptide and protein identification
was set to 1%, and the minimum peptide length was set to 7. The minimum score threshold
for both modified and unmodified peptides was set to 40. The match between runs function
was enabled and proteins were quantified by the MaxLFQ algorithm integrated in the
MaxQuant software [42]. Here, a minimum of two ratio counts and only unique peptides
were considered for protein quantification.
For basic data handling, normalization, statistics and annotation enrichment analysis
we used the freely available open-source bioinformatics platform Perseus
(version 1.6.5.0) [62]. For data visualization we additionally made use of GraphPad
Prism version 9.0.0. Perseus was used for non-supervised hierarchical clustering and
1D annotation enrichment with a two-sided test with Benjamini–Hochberg FDR correc-
tion (FDR = 0.01). Data analysis after uploading the protein groups file obtained from
MaxQuant database searching was performed as described previously [59]. In brief, all
replicate samples were grouped and LFQ-intensities log(2) transformed. Proteins with
less than three valid values in at least one group were removed and missing values
were imputed from a normal distribution around the detection limit (with 0.3 spread
and 1.8 down-shift). Then, a multiple sample ANOVA t test (FDR = 0.01, S0 = 0.1) was
performed to detect enrichments in the different BioID setups.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/ijms22073690/s1, Table S1: Differential BioID interaction profiling of hNaa40 proteoforms. Raw
data files (biological replicates of Naa40, Naa40S and GFP setups) were searched with MaxQuant [60]
using the Andromeda search engine [61] and MS/MS spectra searched against the human Swiss-
Prot database extended with the BirA*Flag and GFP sequences. The match between runs function
was enabled and proteins were quantified by the MaxLFQ algorithm integrated in the MaxQuant
software [42]. Protein expression profiling using a multiple sample ANOVA t test was performed to
reveal differential protein interactors. Log2 transformed LFQ values were grouped for all replicate
samples and only proteins with minimally 3 valid values in at least one setup were considered, overall
permitting differential protein enrichment analysis of 1297 unique proteins. Missing data values were
replaced with imputed values from the corresponding normal distribution around the detection limit.
Overall, from the 973 differential protein groups, 203 (cluster-1) and 176 (cluster-2) protein groups
were enriched in the hNaa40 and hNaa40S setups, respectively. Log2-transformed LFQ intensity
values (with and without data imputation), (majority) protein IDs, protein and gene names, fasta
headers, (cluster) ANOVA significant, ANOVA p- and q-value, GO names (BP: biological process,
MF: molecular function, CC: cellular component), keywords, corum terms, number of (unique/razor)
peptides, unique sequence coverage (%), molecular weight (kDa), MS/MS count, MaxQuant score,
number of (unique/razor) peptides, unique sequence coverage (%), molecular weight (kDa), MS/MS
count are provided for all the BioID samples analyzed., Table S2: 1D annotation enrichment for
hNaa40L and hNaa40S BioID setups. Significantly regulated (FDR < 2%) normalized positive an-
notation enrichment scores (+0.12 to +0.8 max) of UniProt keywords, CORUM and GO (GOMF,
GOCC, GOBP) annotations are shown for hNaa40L and hNaa40S BioID setups. Term enrichment was
determined using the 1D annotation enrichment algorithm embedded in Perseus [44] and p values
were corrected for multiple hypotheses testing using the Benjamini and Hochberg false discovery
rate. Only corrected p values < 0.02 were considered. Size, setup, 1D enrichment score, p value, FDR
and gene annotations (category and names) are provided. Figure S1: Representative MS2 spectrum
matching a doubly charged precursor mass of m/z 935.4205, corresponding to the modified peptide
sequence AAMDAVC < Cmm > AK matching AA-sequence 20 to 28 of hNaa40pL and with ‘Cmm’
and ‘iTRAQ’ denoting a carbamidomethyl and iTRAQ moiety.
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